x

CytoMed Therapeutics Ltd (Nasdaq:GDTC)

Health Care/Life Sciences • Biotechnology
CIK 1873093
Company

CytoMed Therapeutics Ltd. operates as a biopharmaceutical company. It engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.

Address
1 Commonwealth Lane
No. 08-22, One Commonwealth
Singapore, CE 149544
Employees
28
Stock Info
Close
$2.3400
Day Range
2.2400 - 2.3800
52 Week Range
1.9200 - 9.2500
Average volume
53.29K
Short Interest
22.87K (02/15/24)
% of Float Shorted
0.58%
Market Cap
$25.8M
Revenue
N/A
Net Income
-$2.27M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$0.2803
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman
Chee Kong Choo MBA
Chief Operating Officer & Director
Wee Kiat Tan PhD
Director & Chief Clinical Officer
Tien Wee Luk MD
Director, Chief Scientific & Medical Officer
Jieming Zeng MD, PhD
Independent Director
Yuin Han Loh PhD
Independent Director
Chak Hua Yew MD
Independent Non-Executive Director
Kei Wei Leong CPA
Independent Director
Tao Wu
Independent Director
Keng Kiat Toh MD
SEC filings
DateFormEvent
5 Dec, 2024 6-K
20 Nov, 2024 6-K
4 Nov, 2024 144
7 Oct, 2024 6-K
3 Oct, 2024 6-K
30 Sep, 2024 6-K
24 Jun, 2024 6-K/A
20 Jun, 2024 6-K
24 May, 2024 6-K
23 May, 2024 SC 13G/A
25 Apr, 2024 6-K/A
24 Apr, 2024 6-K
22 Apr, 2024 20-F
18 Mar, 2024 6-K
4 Mar, 2024 6-K
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G
29 Jan, 2024 6-K
17 Nov, 2023 6-K
25 Sep, 2023 6-K
1 Aug, 2023 6-K
6 Jul, 2023 6-K
19 May, 2023 SC 13D
1 May, 2023 20-F
24 Apr, 2023 SC 13G
21 Apr, 2023 SC 13D
18 Apr, 2023 6-K
17 Apr, 2023 3
17 Apr, 2023 424B4 IPO completed
17 Apr, 2023 3
14 Apr, 2023 3
14 Apr, 2023 3
14 Apr, 2023 3
14 Apr, 2023 CERT
14 Apr, 2023 3
14 Apr, 2023 3
14 Apr, 2023 3
14 Apr, 2023 3
14 Apr, 2023 3
31 Mar, 2023 CORRESP
31 Mar, 2023 EFFECT
31 Mar, 2023 FWP
31 Mar, 2023 SEC STAFF
31 Mar, 2023 CORRESP
31 Mar, 2023 CORRESP
30 Mar, 2023 F-1/A
30 Mar, 2023 CORRESP
30 Mar, 2023 8-A12B
29 Mar, 2023 UPLOAD
28 Mar, 2023 F-1/A
16 Mar, 2023 F-1/A
15 Mar, 2023 CORRESP
27 Feb, 2023 FWP
24 Feb, 2023 UPLOAD
21 Feb, 2023 F-1/A
21 Feb, 2023 CORRESP
9 Feb, 2023 UPLOAD
1 Feb, 2023 F-1/A
31 Jan, 2023 CORRESP
30 Nov, 2022 UPLOAD
30 Nov, 2022 SEC STAFF
18 Nov, 2022 CORRESP
18 Nov, 2022 F-1
19 Oct, 2022 UPLOAD
30 Sep, 2022 DRS/A
18 Jan, 2022 DRSLTR
7 Jan, 2022 UPLOAD
20 Dec, 2021 DRS/A
17 Dec, 2021 DRSLTR
2 Dec, 2021 UPLOAD
19 Nov, 2021 DRSLTR
19 Nov, 2021 DRS/A
26 Oct, 2021 UPLOAD
28 Sep, 2021 DRS
Last update:2024-03-06 12:31:55.816925
CytoMed Therapeutics Ltd by TradingView

Sign Up to Subscribe